{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:12:26Z","timestamp":1790917946420,"version":"4.1.0"},"reference-count":44,"publisher":"Microbiology Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,5,1]]},"abstract":"<jats:p>Monoclonal antibodies (mAbs) to conserved epitopes on the G glycoprotein of human respiratory syncytial virus (HRSV) subgroup A fail to neutralize the virus in cell culture in the absence of complement, but are protective in rodent models of infection. They may have potential as prophylactic agents in human infants. In order to investigate the role of Fc-dependent pathways in protection by one such antibody, 1C2, the V<jats:sub>H<\/jats:sub>and V<jats:sub>L<\/jats:sub>genes were isolated by RT-PCR and assembled with human<jats:italic>\u03ba<\/jats:italic>light-chain and human<jats:italic>\u03b3<\/jats:italic>1 heavy-chain constant-region genes to form two mouse\u2013human chimaeras, which were expressed in NS0 cells. One of the chimaeras carried a wild-type<jats:italic>\u03b3<\/jats:italic>1 chain, whilst the other had an aglycosyl mutation in the C<jats:sub>H<\/jats:sub>2 domain rendering the antibody defective in complement activation and Fc<jats:italic>\u03b3<\/jats:italic>R binding. Whilst both chimaeric antibodies exhibited similar avidity for HRSV in ELISA, only the fully glycosylated wild type was capable of neutralizing the virus in the presence of complement. In mice passively immunized with either murine or wild-type<jats:italic>\u03b3<\/jats:italic>1 chimaeric antibody, no virus could be recovered from the lungs 4\u2005days after intranasal inoculation of HRSV. In mice immunized with the aglycosyl<jats:italic>\u03b3<\/jats:italic>1 chimaera, however, virus was present in the lungs following challenge, although virus titres were significantly reduced compared with controls (<jats:italic>P<\/jats:italic>&lt;0\u00b7005). These results indicate that the protective effect of this antibody is mediated by both Fc-dependent and Fc-independent pathways.<\/jats:p>","DOI":"10.1099\/vir.0.81660-0","type":"journal-article","created":{"date-parts":[[2006,4,7]],"date-time":"2006-04-07T03:57:39Z","timestamp":1144382259000},"page":"1267-1273","source":"Crossref","is-referenced-by-count":15,"title":["Protection of mice against Human respiratory syncytial virus by wild-type and aglycosyl mouse\u2013human chimaeric IgG antibodies to subgroup-conserved epitopes on the G glycoprotein"],"prefix":"10.1099","volume":"87","author":[{"given":"C.","family":"Mekseepralard","sequence":"first","affiliation":[{"name":"The Schools of Clinical Medical Sciences and Cell and Molecular Biosciences, The University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. L.","family":"Toms","sequence":"additional","affiliation":[{"name":"The Schools of Clinical Medical Sciences and Cell and Molecular Biosciences, The University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. G.","family":"Routledge","sequence":"additional","affiliation":[{"name":"The Schools of Clinical Medical Sciences and Cell and Molecular Biosciences, The University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"345","reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/jmv.1890470203","article-title":"Evaluation of subgroup-specific peptides of the G protein of respiratory syncytial virus for characterization of the immune response","volume":"47","author":"\u00c5kerlind-Stopner","year":"1995","journal-title":"J Med Virol"},{"key":"R2","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0264-410X(97)00033-9","article-title":"Immunization with a peptide derived from the G glycoprotein of bovine respiratory syncytial virus (BRSV) reduces the incidence of BRSV-associated pneumonia in the natural host","volume":"15","author":"Bastien","year":"1997","journal-title":"Vaccine"},{"key":"R3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/eji.1830230216","article-title":"The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties","volume":"23","author":"Bolt","year":"1993","journal-title":"Eur J Immunol"},{"key":"R4","first-page":"1149","article-title":"Pharmacokinetics of the monoclonal antibody B72.3 and its fragments labeled with either 125I or 111In","volume":"47","author":"Brown","year":"1987","journal-title":"Cancer Res"},{"key":"R5","first-page":"1443","article-title":"Respiratory syncytial virus","volume-title":"In Fields Virology","author":"Collins","year":"2001"},{"key":"R6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0264-410X(95)00222-M","article-title":"Involvement of the complement system in the protection of mice from challenge with respiratory syncytial virus Long strain following passive immunization with monoclonal antibody 18A2B2","volume":"14","author":"Corbeil","year":"1996","journal-title":"Vaccine"},{"key":"R7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-3476(03)00213-0","article-title":"Respiratory syncytial virus (RSV) loads in premature infants with and without prophylactic RSV fusion protein monoclonal antibody","volume":"143","author":"DeVincenzo","year":"2003","journal-title":"J Pediatr"},{"key":"R8","doi-asserted-by":"crossref","first-page":"14684","DOI":"10.1021\/bi9621627","article-title":"Solution structure of the immunodominant region of protein G of bovine respiratory syncytial virus","volume":"35","author":"Doreleijers","year":"1996","journal-title":"Biochemistry"},{"key":"R9","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/332738a0","article-title":"The binding site for C1q on IgG","volume":"332","author":"Duncan","year":"1988","journal-title":"Nature"},{"key":"R10","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1128\/JVI.73.8.6610-6617.1999","article-title":"Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G","volume":"73","author":"Feldman","year":"1999","journal-title":"J Virol"},{"key":"R11","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1128\/JVI.74.14.6442-6447.2000","article-title":"The fusion glycoprotein of human respiratory syncytial virus facilitates virus attachment and infectivity via an interaction with cellular heparan sulfate","volume":"74","author":"Feldman","year":"2000","journal-title":"J Virol"},{"key":"R12","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0022-3476(81)80829-3","article-title":"Risk of respiratory syncytial virus infection for infants from low income families in relation to age, sex, ethnic group, and maternal antibody level","volume":"98","author":"Glezen","year":"1981","journal-title":"J Pediatr"},{"key":"R13","first-page":"237","article-title":"Specificity of monoclonal antibody Campath-1","volume":"3","author":"Hale","year":"1988","journal-title":"Bone Marrow Transplant"},{"key":"R14","volume-title":"Antibodies: a Laboratory Manual","author":"Harlow","year":"1988"},{"key":"R15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jmv.1890420402","article-title":"In vivo production of tumour necrosis factor- \u03b1 and interleukin-6 in BALB\/c mice inoculated intranasally with a high dose of respiratory syncytial virus","volume":"42","author":"Hayes","year":"1994","journal-title":"J Med Virol"},{"key":"R16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0092-8674(80)90168-3","article-title":"Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments","volume":"22","author":"Hieter","year":"1980","journal-title":"Cell"},{"key":"R17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high risk infants","volume":"102","year":"1998","journal-title":"Pediatrics"},{"key":"R18","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.4049\/jimmunol.148.10.3062","article-title":"Therapy with monoclonal antibodies. An in vivo model for the assessment of therapeutic potential","volume":"148","author":"Isaacs","year":"1992","journal-title":"J Immunol"},{"key":"R19","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0022-2836(87)90418-9","article-title":"At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells","volume":"196","author":"Kozak","year":"1987","journal-title":"J Mol Biol"},{"key":"R20","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1099\/0022-1317-77-6-1249","article-title":"Proposed three-dimensional model for the attachment protein G of respiratory syncytial virus","volume":"77","author":"Langedijk","year":"1996","journal-title":"J Gen Virol"},{"key":"R21","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1099\/0022-1317-78-10-2411","article-title":"Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein","volume":"78","author":"Melero","year":"1997","journal-title":"J Gen Virol"},{"key":"R22","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1099\/0022-1317-68-11-2781","article-title":"Strain variation of respiratory syncytial virus","volume":"68","author":"Morgan","year":"1987","journal-title":"J Gen Virol"},{"key":"R23","first-page":"101","article-title":"Complement activation an Fc receptor binding by IgG","volume-title":"In Protein Engineering of Antibody Molecules for Prophylactic and Therapeutic Application in Man","author":"Morrison","year":"1993"},{"key":"R24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/jmv.1890070403","article-title":"Maternal antibody and respiratory syncytial virus infection in infancy","volume":"7","author":"Ogilvie","year":"1981","journal-title":"J Med Virol"},{"key":"R25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1128\/JVI.63.1.411-420.1989","article-title":"Processing, surface expression, and immunogenicity of carboxy-terminally truncated mutants of G protein of human respiratory syncytial virus","volume":"63","author":"Olmsted","year":"1989","journal-title":"J Virol"},{"key":"R26","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1073\/pnas.86.10.3833","article-title":"Cloning immunoglobulin variable domains for expression by the polymerase chain reaction","volume":"86","author":"Orlandi","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R27","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/(SICI)1096-9071(200004)60:4<468::AID-JMV16>3.0.CO;2-E","article-title":"Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains","volume":"60","author":"Palomo","year":"2000","journal-title":"J Med Virol"},{"key":"R28","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1128\/JVI.73.7.5637-5645.1999","article-title":"Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein","volume":"73","author":"Plotnicky-Gilquin","year":"1999","journal-title":"J Virol"},{"key":"R29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1099\/0022-1317-69-2-293","article-title":"The purification of four respiratory syncytial virus proteins and their evaluation as protective agents against experimental infection in BALB\/c mice","volume":"69","author":"Routledge","year":"1988","journal-title":"J Gen Virol"},{"key":"R30","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/eji.1830211111","article-title":"A humanized monovalent CD3 antibody which can activate homologous complement","volume":"21","author":"Routledge","year":"1991","journal-title":"Eur J Immunol"},{"key":"R31","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1099\/0022-1317-67-7-1479","article-title":"A neutralizing monoclonal antibody to respiratory syncytial virus which binds to both F1 and F2 components of the fusion protein","volume":"67","author":"Samson","year":"1986","journal-title":"J Gen Virol"},{"key":"R32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0264-410X(97)00189-8","article-title":"Subgroup specific protection of mice from respiratory syncytial virus infection with peptides encompassing the amino acid region 174-187 from the G glycoprotein: the role of cysteinyl residues in protection","volume":"15","author":"Simard","year":"1997","journal-title":"Vaccine"},{"key":"R33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1128\/JVI.60.2.607-613.1986","article-title":"Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challenge","volume":"60","author":"Stott","year":"1986","journal-title":"J Virol"},{"key":"R34","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0092-8674(82)90183-0","article-title":"Structure of human immunoglobulin gamma genes: implications for evolution of a gene family","volume":"29","author":"Takahashi","year":"1982","journal-title":"Cell"},{"key":"R35","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.4049\/jimmunol.143.8.2595","article-title":"Studies of aglycosylated chimaeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region","volume":"143","author":"Tao","year":"1989","journal-title":"J Immunol"},{"key":"R36","first-page":"17","article-title":"The role of antibody in controlling and\/or clearing virus infections","volume-title":"In Strategies in Vaccine Design","author":"Taylor","year":"1994"},{"key":"R37","first-page":"137","article-title":"Monoclonal antibodies protect against respiratory syncytial virus infection in mice","volume":"52","author":"Taylor","year":"1984","journal-title":"Immunology"},{"key":"R38","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/viro.2001.1138","article-title":"Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo","volume":"289","author":"Teng","year":"2001","journal-title":"Virology"},{"key":"R39","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/90675","article-title":"CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein","volume":"2","author":"Tripp","year":"2001","journal-title":"Nat Immunol"},{"key":"R40","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0042-6822(91)90546-N","article-title":"Protection of BALB\/c mice from respiratory syncytial virus infection by immunization with a synthetic peptide derived from the G glycoprotein","volume":"185","author":"Trudel","year":"1991","journal-title":"Virology"},{"key":"R41","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1128\/IAI.43.2.756-758.1984","article-title":"Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies","volume":"43","author":"Walsh","year":"1984","journal-title":"Infect Immun"},{"key":"R42","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1099\/0022-1317-64-9-1867","article-title":"Antibodies to respiratory syncytial virus polypeptides and their significance in human virus infection","volume":"64","author":"Ward","year":"1983","journal-title":"J Gen Virol"},{"key":"R43","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1099\/0022-1317-75-10-2813","article-title":"Biological activity, binding site and affinity of monoclonal antibodies to the fusion protein of respiratory syncytial virus","volume":"75","author":"West","year":"1994","journal-title":"J Gen Virol"},{"key":"R44","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s002390010147","article-title":"Variable immune-driven natural selection in the attachment (G) glycoprotein of respiratory syncytial virus (RSV)","volume":"52","author":"Woelk","year":"2001","journal-title":"J Mol Evol"}],"container-title":["Journal of General Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.81660-0?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T16:49:13Z","timestamp":1706978953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.81660-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,1]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5,1]]}},"URL":"https:\/\/doi.org\/10.1099\/vir.0.81660-0","relation":{},"ISSN":["0022-1317","1465-2099"],"issn-type":[{"value":"0022-1317","type":"print"},{"value":"1465-2099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,1]]}}}